Bionano Genomics (BNGO) Amortizatization of Intangibles (2021 - 2026)
Bionano Genomics (BNGO) reported Amortizatization of Intangibles of $194000.0 for Q1 2026, down 19.83% on a YoY basis from $242000.0 in Q1 2025, and up 137.09% sequentially from -$523000.0 in Q4 2025.
Bionano Genomics (BNGO) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Bionano Genomics (BNGO) has 6 years of Amortizatization of Intangibles data on file, last reported at $194000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 19.83% year-over-year to $194000.0; the trailing twelve-month figure through Mar 2026 stood at $156000.0 (down 81.94% YoY), and the FY2025 full-year result was $204000.0, down 84.5% from the prior year.
- Amortizatization of Intangibles climbed to $194000.0 in Q1 2026, from -$523000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.2 million in Q4 2024 to a low of -$759000.0 in Q3 2024.
- A 5-year average of $95000.0 and a median of $57000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Peak annual rise in Amortizatization of Intangibles reached 1260.78% in 2024, while the deepest fall reached 1588.24% in 2024.
- Tracing BNGO's Amortizatization of Intangibles over 5 years: stood at $57000.0 in 2022, then surged by 577.19% to $386000.0 in 2023, then soared by 201.3% to $1.2 million in 2024, then tumbled by 144.97% to -$523000.0 in 2025, then soared by 137.09% to $194000.0 in 2026.
- Business Quant data shows BNGO's Amortizatization of Intangibles at $194000.0 in Q1 2026, -$523000.0 in Q4 2025, and $236000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 8.80 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | - |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 500,000.00 |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | - |
| 10 | Bionano Genomics | 11.87 Mn | -1.82 Mn | 3.25 Mn | 194,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 194,000.00 |
| Mar 31, 2026 | 194,000.00 |
| Dec 31, 2025 | -523,000.00 |
| Dec 31, 2025 | -523,000.00 |
| Sep 30, 2025 | 236,000.00 |
| Sep 30, 2025 | 236,000.00 |
| Jun 30, 2025 | 249,000.00 |
| Jun 30, 2025 | 249,000.00 |
| Mar 31, 2025 | 242,000.00 |
| Mar 31, 2025 | 242,000.00 |
| Dec 31, 2024 | 1.16 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | -759,000.00 |
| Sep 30, 2024 | -759,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Mar 31, 2024 | 694,000.00 |
| Mar 31, 2024 | 694,000.00 |
| Dec 31, 2023 | 386,000.00 |
| Dec 31, 2023 | 386,000.00 |